AMBALAL SARABHAI share price has zoomed 6% and is presently trading at Rs 49.0.
Meanwhile, the BSE HEALTHCARE index is at 37,395.2 (up 0.6%).
Among the top gainers in the BSE HEALTHCARE index today are SUN PHARMA ADV. RES. (up 2.8%) and FORTIS HEALTHCARE (up 2.6%).
ALEMBIC PHARMA (down 2.0%) and AARTI DRUGS (down 1.7%) are among the top losers today.
Over the last one year, AMBALAL SARABHAI has moved up from Rs 28.5 to Rs 49.0, registering a gain of Rs 20.5 (up 72.2%).
On the other hand, the BSE HEALTHCARE index has moved up from 25,627.6 to 37,395.2, registering a gain of 45.9% during the last 12 months.
The top gainers among the BSE HEALTHCARE index stocks during this same period were Glenmark Pharma (up 90.4%), Cadila Healthcare (up 90.2%) and GSK Pharma (up 87.5%).
Must See: These Segments are Witnessing Incredible Growth with Modi's Push
The BSE Sensex is at 79,882.2 (up 0.6%).
The top gainers among the BSE Sensex today are HDFC Bank (up 3.1%) and Axis Bank (up 1.9%). The most traded stocks in the BSE Sensex are Tata Steel and HDFC Bank.
In the meantime, NSE Nifty is at 24,265.5 (up 0.6%). HDFC Bank and Tata Consumer Products are among the top gainers in NSE NIFTY.
Over the last 12 months, the BSE Sensex has moved up from 65,205.1 to 79,882.2, registering a gain of 14,677.2 points (up 22.5%).
AMBALAL SARABHAI net profit grew 131.5% YoY to Rs 101 million for the quarter ended March 2024, compared to a profit of Rs 44 million a year ago. Net sales rose 22.3% to Rs 543 million during the period as against Rs 444 million in January-March 2023.
For the year ended March 2024, AMBALAL SARABHAI reported 50.4% decrease in net profit to Rs 57 million compared to net profit of Rs 114 million during FY23. Revenue of the company grew 1.9% to Rs 1,736 million during FY24.
The current Price to earnings ratio of AMBALAL SARABHAI, based on rolling 12 month earnings, stands at 44.7.
Equitymaster requests your view! Post a comment on "AMBALAL SARABHAI Gains 6%; BSE HEALTHCARE Index Up 0.6%". Click here!
Comments are moderated by Equitymaster, in accordance with the Terms of Use, and may not appear
on this article until they have been reviewed and deemed appropriate for posting.
In the meantime, you may want to share this article with your friends!